Last reviewed · How we verify

NCT06626347: TREAT-ED

Telemedicine for Reach, Education, Access, and Treatment for Diabetes Self-Management Education and Support

Active, enrolled NA Last updated 17 February 2026
What this trial tests

NA trial testing TREAT-ED Virtual Group Diabetes Self-Management Education and Support in Type 1 Diabetes (T1D) in 49 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
8 November 2024
Primary endpoint
31 January 2026
31 May 2026

Quick facts

Lead sponsorUniversity of Pittsburgh
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment49
Start date8 November 2024
Primary completion31 January 2026
Estimated completion31 May 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pittsburgh

Who can join

Adults 18 to 26, any sex, with Type 1 Diabetes (T1D). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Emerging adults with type 1 diabetes are a vulnerable population. While diabetes self-management and education is known to offer opportunities to develop self-management skills required to achieve and maintain short- and long-term diabetes outcomes, emerging adults are reported to have poor clinic attendance and in turn low participation in diabetes self-management education and support services. This pilot study aims to test a novel approach to diabetes self-management education and support that incorporates technological and applied learning-driven methods delivered through group telemedicine visits to improve emerging adults engagement in diabetes self-management education and support with the ultimate goal of improving diabetes outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes (T1D)

Currently open trials in the same condition.

Other University of Pittsburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06626347.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing